Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients.
Seljeflot
I
I
Larsen
J R
JR
Dahl-Jørgensen
K
K
Hanssen
K F
KF
Arnesen
H
H
D000328:Adult; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D005260:Female; D005342:Fibrinolysis; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D006454:Hemoglobins; D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human; D014409:Tumor Necrosis Factor-alpha; C058244:acetylated hemoglobin